CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 1,854 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 14,343 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 9,000 shares (option exercise)
- 4 Open-market sale CFO and Treasurer sold 15,000 shares at $21.15 ($317,250)
- 4 Open-market sale President and CEO sold 48,967 shares at $21.10 ($1,033,204)
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 2,647 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 21,752 shares (to pay taxes)
- 4 Open-market sale Director sold 9,000 shares at $18.47 ($166,189)
- 4 Open-market sale COO and SVP, Compliance sold 24,150 shares at $16.90 ($408,050)
- 4 Open-market sale Director sold 136,861 shares at $17.27 ($2,363,932)
- 4 Open-market sale President and CEO sold 626,245 shares at an average $17.44 ($10,923,987)
- 4 Open-market sale Director sold 60,000 shares at $18.26 ($1,095,600)
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 2,502 shares (to pay taxes)
- 4 Grant or award CFO and Treasurer acquired 72,400 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 2,085 shares (to pay taxes)
- 4 Shares withheld for taxes President,CEO, and Interim CFO gave up 21,752 shares (to pay taxes)
- 4 Open-market sale President,CEO, and Interim CFO sold 100,000 shares at $10.72 ($1,071,980)
Page 4 of 19 · 362 filings